BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24934)

  • 1. [Measles morbidity against a background of mass vaccinal prophylaxis in Kara-Su District, Osh Province].
    Nurakhunov NN
    Zdravookhr Kirg; 1978; (1):27-31. PubMed ID: 24934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Basic indices of measles incidence in the years of mass inoculations with live measles vaccine].
    Shul'ga OE; Siniak KM
    Vrach Delo; 1979 May; (5):103-7. PubMed ID: 452582
    [No Abstract]   [Full Text] [Related]  

  • 3. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic response and reactions to vaccination in children vaccinated against measles. III. Persistence of measles antibodies in children vaccinated in 1972].
    Kańtoch M; Naruszewicz-Lesiuk D; Polna I; Lityńska J
    Przegl Epidemiol; 1976; 30(2):235-41. PubMed ID: 945592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 6. [Humoral response against measles in children 7 years following vaccination].
    Wroczyńska-Palka M; Morzycka M; Chrapowicki T; Krauze-Kancewicz B
    Pol Tyg Lek; 1976 Jun; 31(24):1017-20. PubMed ID: 951270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of seropositive children against measles in Tanzania: boosting of antibody titres or a statistical artifact.
    Mandara MP; Remme J
    East Afr Med J; 1985 Jan; 62(1):12-20. PubMed ID: 4006810
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of vaccinated individuals in measles morbidity during the vaccination period].
    Deshevoĭ SE; Makarova NT; Petrova VN; Malykhina RM
    Tr Inst Im Pastera; 1983; 61():158-64. PubMed ID: 6235629
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measles: notes on epidemiology and prevention, including the military community].
    Zardi O
    Riv Med Aeronaut Spaz; 1979; 42(1-2):124-60. PubMed ID: 400041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Status of immunity after measles vaccination (author's transl)].
    La Cauza C; Galluzzi F; Salti R
    Ann Sclavo; 1980; 22(4):545-54. PubMed ID: 7018418
    [No Abstract]   [Full Text] [Related]  

  • 18. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 19. [Optimal age for vaccination against measles].
    José MV; Kumate J
    Salud Publica Mex; 1989; 31(5):645-57. PubMed ID: 2692194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L
    Tr Inst Im Pastera; 1979; 53():19-25. PubMed ID: 262709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.